Silva Pharmaceuticals Limited announcements
119 Dhaka Stock Exchange announcements for Silva Pharmaceuticals Limited (SILVAPHL) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (18).
- The company has informed that the agenda about the time extension for utilization of IPO Proceeds has been approved by t
The company has informed that the agenda about the time extension for utilization of IPO Proceeds has been approved by the Shareholders of the company in its 21st AGM held on December 29, 2022 at 11:00 AM. The utilization of IPO proceeds has been extended up to December 31, 2023. The Company has also informed the reason for increasing the time for utilization of IPO fund is that, due to COVID-19 (cont.)
- Time extension of IPO proceeds utilization
(Continuation news of SILVAPHL): pandemic and the ongoing Russia-Ukraine geopolitical situation which has caused supply chain disruptions as well as additional cost pressure for devaluation of BDT against USD as well as market uncertainties, the company has not wholly completed the import of related some Capital machinery & Equipment from abroad in the scheduled time. (end)
The first part of this announcement is missing from the archive. - Resumption after record date
Trading of the shares of the Company will resume on 04.12.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 01.12.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 29.11.2022 to 30.11.2022. Trading of the shares will remain suspended on record date i.e., 01.12.2022.
- (Q1 Un-audited): EPS was Tk. 0.19 for July-September 2022 as against Tk. 0.29 for July-September 2021; NOCFPS was Tk. 0.
(Q1 Un-audited): EPS was Tk. 0.19 for July-September 2022 as against Tk. 0.29 for July-September 2021; NOCFPS was Tk. 0.27 for July-September 2022 as against Tk. 0.45 for July-September 2021. NAV per share was Tk. 17.22 as on September 30, 2022 and Tk. 17.03 as on June 30, 2022. (cont.)
- Q1 Financials
(Continuation news of SILVAPHL): Reasons for deviation in EPS and NOCFPS: EPS has been decreased due to supply chain disruption resulting from on going Russia-Ukraine geo-political situation, deviation of BDT against US Dollar, decrease in sales volume and increase in material cost. NOCFPS has been decreased due to decrease in collection from receivables as well as sales. (end)
The first part of this announcement is missing from the archive. - The auditor of the Silva Pharmaceuticals Limited has given the \"Emphasis of matter\" paragraph in the Auditor\'s Report
The auditor of the Silva Pharmaceuticals Limited has given the \"Emphasis of matter\" paragraph in the Auditor\'s Report for the year ended 30 June, 2022. Emphasis of matter: Property plant & equipment: Detailed fixed asset (PPE) register is to be maintained properly. Physical verification (PPE) to be conducted in every year. Our opinion is not modified in respect of this matter.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- The Board of Directors has recommended 3\% cash dividend for shareholders excluding the Sponsors/Directors (except 1.5\%
The Board of Directors has recommended 3\% cash dividend for shareholders excluding the Sponsors/Directors (except 1.5\% for ICB) for the year ended June 30, 2022. The Sponsors/Directors, who shall not be entitled to any cash dividend, hold 41,517,000 shares out of total 136,500,000 shares. The total amount of cash dividend payable to the general shareholders including ICB is Tk. 24,189,812.00 only for 94,983,000 shares. Date of AGM: 29.12.2022, Time: 11:00 AM, (cont.)
- Dividend Declaration
(Continuation news of SILVAPHL): Venue: Digital Platform, Record Date: 01.12.2022. The Company has reported EPS of Tk. 0.75, NAV per share of Tk. 17.03 and NOCFPS of Tk. 1.18 for the year ended June 30, 2022 as against Tk. 0.88, Tk. 16.63 and Tk. 1.17 respectively for the same period of the previous year. Reason for deviation in EPS: EPS has decreased as revenue has been decreased and the cost of goods sold have been increased due to raw material price increased in local and international market. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.10.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.22 for January-March 2022 as against Tk. 0.19 for January-March 2021; EPS was Tk. 0.73 for July 2021-March 2022 as against Tk. 0.73 for July 2020-March 2021. NOCFPS was Tk. 1.14 for July 2021-March 2022 as against Tk. 0.95 for July 2020-March 2021. NAV per share was Tk. 17.01 as on March 31, 2022 and Tk. 16.63 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the company has informed that a meeting of the Board of Directors will be held on April 26, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the company for the Third Quarter (Q3) period ended March 31, 2022.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.22 for October-December 2021 as against Tk. 0.20 for October-December 2020; EPS was Tk. 0.50 for July-December 2021 as against Tk. 0.54 for July-December 2020. NOCFPS was Tk. 0.82 for July-December 2021 as against Tk. 0.68 for July-December 2020. NAV per share was Tk. 17.14 as on December 31, 2021 and Tk. 16.63 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.